Breath Biopsy Tests
Developing Breath Biopsy for clinical applications in early detection and precision medicine.
Most popular related searches
A Robust Pipeline for Rapid Biomarker Panel Development and Test Delivery
Through Breath Biopsy Tests, we aim to realize our mission of saving 100,000 lives and $1.5B in healthcare costs by applying our expertise in breath biomarker discovery and analysis to the areas of greatest clinical need. We constantly assess the latest developments in research and healthcare to identify opportunities for Breath Biopsy to make a difference to early detection of disease or the implementation of precision medicine. Our primary areas of focus are in cancer, liver disease, and respiratory disease, however the potential range of applications of Breath Biopsy is very broad and we are exploring many other uses both internally and through our partnerships.
To develop high-impact breath solutions, we deploy a two-stage development pipeline. Initially, we combine internal expertise, published scientific knowledge and our own research results to develop Research Use Only (RUO) Panels, based primarily on the content of our evolving global biomarker service Breath Biopsy OMNI. Once on market, we further develop and refine these RUO Panels until we are ready to seek in vitro diagnostic device (IVD) status when appropriate.
No reviews were found for Breath Biopsy Tests. Be the first to review!